

Single Cell Sequencing Platform Market Scope: Industry Analysis, Market Size, Growth, Trends Till
Request Sample Report
The Single Cell Sequencing Platform market is poised for substantial growth, driven by advancements in genomics and personalized medicine. Current market size is estimated at approximately $2 billion, with projections to reach over $5 billion by 2028. Key drivers include technological innovations and increased research funding in genomics.
◍ 10x Genomics
◍ BD
◍ Fluidigm Corporation
◍ Illumina/Bio-Rad
◍ Takara Bio
◍ 1CellBio
◍ MissionBio
The Single Cell Sequencing Platform Market features key players like 10x Genomics, BD, Fluidigm, Illumina/BioRad, Takara Bio, 1CellBio, and Mission Bio. These companies innovate, enhance research capabilities, and drive market growth through advanced technologies. Sales figures include:
- 10x Genomics: ~$490 million
- Illumina: ~$3.2 billion
- Fluidigm: ~$81 million
Request Sample Report
Neurobiology
Immunology ◍ Cancer Medicine ◍ Plant Biology
Forensics
Other
◍ Microfluidic Separation ◍ Microdroplet Separation ◍ Microporous Separation
Combined Labeling
Other
Request Sample Report
Request Sample Report
$ 9.83 Billion